News

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...
The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...
The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.
Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...
After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...
Moderna (NASDAQ: MRNA) stock represented the ticket to an investing win. The company brought its coronavirus vaccine from ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...